Alaa Fayed
10.2147/IMCRJ.S383541
Int Med Case Rep J
2022 Oct 18;15:593-598.
best vegf lipofuscin macular neovascularization ranibizumab vitelliform
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36281445/
Case Reports
PMC9587723
36281445
Temporary Vitelliform Regression After Intravitreal Ranibizumab Injection for Macular Neovascularization Complicating Best Disease
2022